PT  - JOURNAL ARTICLE
AU  - Sophia Schiza
AU  - Charalampos Mermigkis
AU  - George A. Margaritopoulos
AU  - Zoi Daniil
AU  - Sergio Harari
AU  - Venerino Poletti
AU  - Elizabetta A. Renzoni
AU  - Olga Torre
AU  - Dina Visca
AU  - Isolde Bouloukaki
AU  - George Sourvinos
AU  - Katerina M. Antoniou
TI  - Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night
AID  - 10.1183/16000617.00009114
DP  - 2015 Jun 01
TA  - European Respiratory Review
PG  - 327--339
VI  - 24
IP  - 136
4099  - http://err.ersjournals.com/content/24/136/327.short
4100  - http://err.ersjournals.com/content/24/136/327.full
SO  - EUROPEAN RESPIRATORY REVIEW2015 Jun 01; 24
AB  - The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines recognise OSA as an important associated comorbidity that can affect patient's survival. Thus, it becomes conceivable that clinicians should refer patients with newly diagnosed IPF to sleep centres for the diagnosis and treatment of OSA as well as for addressing issues regarding the reduced compliance of patients with continuous positive airway pressure therapy. The discovery of biomarkers common to both disorders may help early diagnosis, institution of the most appropriate treatment and follow-up of patients. Better understanding of epigenetic changes may provide useful information about pathogenesis and, possibly, development of new drugs for a dismal disease like IPF. It is now believed that IPF and sleep disorders can coexist in the same patient http://ow.ly/LXPSL